United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
260.51
-1.89 (-0.72%)
May 6, 2024, 4:00 PM EDT - Market closed
United Therapeutics Revenue
United Therapeutics had revenue of $2.50B in the twelve months ending March 31, 2024, with 26.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $677.70M with 33.70% year-over-year growth. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.
Revenue (ttm)
$2.50B
Revenue Growth
+26.09%
P/S Ratio
4.63
Revenue / Employee
$2,138,955
Employees
1,168
Market Cap
11.56B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.33B | 391.20M | 20.20% |
Dec 31, 2022 | 1.94B | 250.80M | 14.88% |
Dec 31, 2021 | 1.69B | 202.20M | 13.63% |
Dec 31, 2020 | 1.48B | 34.50M | 2.38% |
Dec 31, 2019 | 1.45B | -179.00M | -11.00% |
Dec 31, 2018 | 1.63B | -97.50M | -5.65% |
Dec 31, 2017 | 1.73B | 126.50M | 7.91% |
Dec 31, 2016 | 1.60B | 133.00M | 9.07% |
Dec 31, 2015 | 1.47B | 177.30M | 13.76% |
Dec 31, 2014 | 1.29B | 171.52M | 15.36% |
Dec 31, 2013 | 1.12B | 200.91M | 21.93% |
Dec 31, 2012 | 916.08M | 172.89M | 23.26% |
Dec 31, 2011 | 743.18M | 150.28M | 25.35% |
Dec 31, 2010 | 592.90M | 234.02M | 65.21% |
Dec 31, 2009 | 358.88M | 77.38M | 27.49% |
Dec 31, 2008 | 281.50M | 70.55M | 33.45% |
Dec 31, 2007 | 210.94M | 51.31M | 32.14% |
Dec 31, 2006 | 159.63M | 43.72M | 37.71% |
Dec 31, 2005 | 115.92M | 42.33M | 57.51% |
Dec 31, 2004 | 73.59M | 20.25M | 37.96% |
Dec 31, 2003 | 53.34M | 23.22M | 77.09% |
Dec 31, 2002 | 30.12M | 24.39M | 425.56% |
Dec 31, 2001 | 5.73M | 3.68M | 179.70% |
Dec 31, 2000 | 2.05M | 1.61M | 369.42% |
Dec 31, 1999 | 436.50K | 382.75K | 712.08% |
Dec 31, 1998 | 53.75K | -62.16K | -53.63% |
Dec 31, 1997 | 115.91K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.91B |
DaVita | 12.34B |
Solventum | 8.20B |
Smith & Nephew | 5.55B |
Charles River Laboratories International | 4.13B |
Catalent | 4.10B |
Incyte | 3.77B |
Exact Sciences | 2.50B |
UTHR News
- 5 days ago - United Therapeutics Corporation Reports First Quarter 2024 Financial Results - Business Wire
- 10 days ago - CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 12 days ago - United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 12 days ago - United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 - Business Wire
- 20 days ago - United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference - Business Wire
- 5 weeks ago - United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation - Business Wire
- 6 weeks ago - United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program - Business Wire
- 2 months ago - United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 - Business Wire